✦ LIBER ✦

Virus safety considerations for recombinant factor VIII (rFVIII, Kogenate)

✍ Scribed by DEBRA ARNOLD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical development of recombinant fact

✍ D. HURST 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Evolution of recombinant factor VIII saf

✍ Jeanne M. Lusher; Inge Scharrer 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 230 KB

Immune function in patients receiving re

✍ Christine A. Lee 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Stability, efficacy, and safety of conti

✍ U. MARTINOWITZ; J. LUBOSHITZ; D. BASHARI; B. RAVID; E. GORINA; L. REGAN; H. STAS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Efficacy and safety evaluation of sucros

✍ J.-H. YOUNG; H.-C. LIU; E.-J. HSUEH; M.-L. HUANG; C.-T. PENG; R.-L. CHEN; M. MAA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Plasma and albumin-free recombinant fact

✍ V. S. BLANCHETTE; A. D. SHAPIRO; R. J. LIESNER; F. HERNÁNDEZ NAVARRO; I. WARRIER 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB